Plain-English translation of NCT02660645 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bladder Cancer research guide →This trial is gathering real-world data on a special imaging procedure called blue light cystoscopy using Cysview®, a medication that helps doctors see bladder cancer more clearly during examination. Researchers want to understand whether this blue light approach finds more cancers than traditional white light cystoscopy, and whether finding more cancers early leads to better outcomes for patients.
Standard cystoscopy (a camera exam of the bladder) sometimes misses early or small cancers. This medication makes cancerous tissue glow under blue light, which may help doctors spot tumors they would otherwise miss and prevent cancer from coming back.
You likely qualify if…
You likely don't qualify if…
If you join this registry, your doctor will perform a cystoscopy procedure where a special medication is instilled into your bladder and allowed to stay there for 1–3 hours before the examination begins. During the procedure, blue light imaging is used to help find any cancerous tissue. Researchers will collect information about your medical history, test results, and how well the blue light imaging works in finding cancers compared to standard white light examination.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States